Another batch of phony cancer drugs has made its way into the U.S., the Food and Drug Administration says.
U.S.-based medical practices purchased vials of counterfeit medicine labeled as Altuzan from a foreign supplier, FDA spokesperson Shelly Burgess tells Shots. She said the agency doesn't have any reports of patients having received the counterfeit drugs.
Altuzan is the Turkish brand name for Avastin, the FDA-approved blockbuster cancer drug from Swiss drugmaker Roche's Genentech unit. Altuzan is approved for use in Turkey — but not in the U.S.